美国 · 平台与数据 · Finviz

Relmada Therapeutics to Report Third Quarter 2026 Financial Results on Thursday, November 12, 2026

来源：Finviz · 美国 20 小时前

Relmada Therapeutics, Inc. (Nasdaq: RLMD, “Relmada” or the “Company”), a clinical-stage biotechnology company advancing innovative therapies for oncology and central nervous…

在 Finviz 阅读全文登录后可收藏

MarketNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (finviz.com)

Relmada Therapeutics to Report Third Quarter 2026 Financial Results on Thursday, November 12, 2026

推荐阅读

Big Tech’s $500 billion spending spree leaves a lot less for shareholders

ConocoPhillips Q3 preview: High expectations as upstream focus drives growth

IPG Photonics: 3 Key Takeaways for Long-Term Investors

Democrats win control of Congress as voters rebuke Trump agenda

Treasury yields fall after Democrats win House and Senate majorities

Best Stocks Under $5

Relmada Therapeutics to Report Third Quarter 2026 Financial Results on Thursday, November 12, 2026

分享

推荐阅读

Big Tech’s $500 billion spending spree leaves a lot less for shareholders

ConocoPhillips Q3 preview: High expectations as upstream focus drives growth

IPG Photonics: 3 Key Takeaways for Long-Term Investors

Democrats win control of Congress as voters rebuke Trump agenda

Treasury yields fall after Democrats win House and Senate majorities

Best Stocks Under $5